Hyundai Bioscience Co., Ltd. (048410.KQ) KOE

5,290.00

+40(+0.76%)

Updated at October 24 03:30PM

Currency In KRW

Hyundai Bioscience Co., Ltd.

Address

Academic Cooperation Building

Seoul, 03759

Korea, Republic of

Phone

82 70 7008 0114

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

54

First IPO Date

August 28, 2002

Key Executives

NameTitlePayYear Born
Jong-Won ChoiJoint Chief Executive Officer01967
Ho-Suk ChonJoint Chief Executive Officer01958
Seok-Yong ChoiChief Operating Officer and Senior Managing Director01962
Yeong-Jin KimPresident01970

Description

Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.